Emcure Pharmaceuticals Ltd. - Research Center
544210 EMCURE Group (B) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Jun' 24 |
Sales |
970.29 |
Operating profit |
115.19 |
Interest |
37.57 |
Gross profit |
110.13 |
EPS (Rs) |
2.23 |
Quarterly
results in details
|
Jun' 24 |
Other income |
32.51 |
Stock adjustment |
-8.42 |
Raw material |
266.07 |
Power and fuel |
- |
Employee expenses |
195.09 |
Excise |
- |
Admin and selling expenses |
- |
Research and development expenses |
- |
Expenses capitalised |
- |
Other expenses |
402.36 |
Provisions made |
- |
Depreciation |
55.08 |
Taxation |
14.60 |
Net profit / loss |
40.45 |
Extra ordinary item |
- |
Prior year adjustments |
- |
Equity capital |
181.15 |
Equity dividend rate |
- |
Agg.of non-prom. shares (Lacs) |
- |
Agg.of non promotoholding (%) |
- |
OPM (%) |
11.87 |
GPM (%) |
10.98 |
NPM (%) |
4.03 |